argenx SE (CHIX:ARGXb) Stock News, Headlines & Updates
argenx SE Stock News from GuruFocus
- 1
- 2
Jul 18, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
Marketwired • 11:00am
Jul 17, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
PRNewswire • 10:00am
Jul 14, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
Marketwired • 9:00am
Jul 12, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
PRNewswire • 10:00am
Jul 10, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
Marketwired • 8:00am
Jul 07, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
PRNewswire • 3:00pm
Jul 06, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
Marketwired • 9:00am
Jul 02, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
PRNewswire • 10:00am
Jul 01, 2025
ARGX Stock: HC Wainwright & Co. Reiterates Buy Rating with $720 Target | ARGX Stock News
GuruFocus News • 6:01am
Jun 30, 2025
Argenx (ARGX) Shares Drop on FDA Alert for Vyvgart Hytrulo
GuruFocus News • 11:57am
argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes | ARGX Stock News
GuruFocus News • 12:15am
argenx SE (ARGX) Advances ARGX-119 to Registrational Study for Congenital Myasthenic Syndromes | ARGX stock news
GuruFocus News • 12:01am
argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes
Marketwired • 12:00am
Jun 24, 2025
argenx (ARGX) Receives Reiterated "Outperform" Rating from Wedbush | ARGX Stock News
GuruFocus News • 9:01am
Jun 20, 2025
Argenx (ARGX) Gains EU Approval for Vyvgart Injection
GuruFocus News • 1:57pm
Argenx (ARGX) Price Target Adjusted by Morgan Stanley Analyst | ARGX Stock News
GuruFocus News • 1:15pm
Argenx (ARGX) Gains European Approval for VYVGART with ENHANZE Technology | ARGX Stock News
GuruFocus News • 12:45pm
European Commission Approves Argenx (ARGX) Therapy for CIDP Treatment | ARGX Stock News
GuruFocus News • 12:15pm
argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy | ARGX Stock News
GuruFocus News • 12:15pm
argenx SE (ARGX) Gains European Approval for VYVGART® SC in CIDP Treatment | ARGX stock news
GuruFocus News • 12:01pm
argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy
Marketwired • 12:00pm
Jun 11, 2025
argenx (ARGX) Maintains Outperform Rating with $715 Target Price | ARGX Stock News
GuruFocus News • 8:00am
ARGX: HC Wainwright & Co. Reiterates Buy Rating with $720 Target Price | ARGX Stock News
GuruFocus News • 6:31am
Jun 10, 2025
argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's Disease
Marketwired • 6:00pm
argenx (ARGX) Shares Positive VYVGART Study Outcomes and FDA Fast Track Status | ARGX Stock News
GuruFocus News • 5:30pm
argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's Disease | ARGX Stock News
GuruFocus News • 5:15pm
HC Wainwright & Co. Reiterates Buy Rating for argenx (ARGX) with $720 Price Target | ARGX Stock News
GuruFocus News • 6:31am
Jun 04, 2025
Barclays Boosts Argenx (ARGX) Price Target to EUR 680 | ARGX Stock News
GuruFocus News • 2:45pm
Jun 03, 2025
argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference | ARGX Stock News
GuruFocus News • 12:15am
argenx SE (ARGX) Announces CFO's Participation in Goldman Sachs Healthcare Conference | ARGX stock news
GuruFocus News • 12:00am
argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
Marketwired • 12:00am
Jun 02, 2025
Argenx (ARGX) Stock Shows Undervalued Potential Amid Market Concerns | ARGX Stock News
GuruFocus News • 10:15am
May 28, 2025
argenx SE (ARGX) Announces Results of Annual General Meeting | ARGX stock news
GuruFocus News • 4:06pm
argenx Announces Results of Annual General Meeting of Shareholders
Marketwired • 4:00pm
Argenx (ARGX) Secures Spot on Wedbush's Best Ideas List | ARGX Stock News
GuruFocus News • 8:18am
May 21, 2025
Argenx (ARGX) Poised for Growth Despite Vyvgart Slowdown Concerns | ARGX Stock News
GuruFocus News • 5:46am
May 14, 2025
Argenx (ARGX) Target Adjusted by Analyst, Outlook Remains Positive | ARGX Stock News
GuruFocus News • 5:19am
May 13, 2025
argenx (ARGX) Receives Positive Rating Update from Baird | ARGX Stock News
GuruFocus News • 8:01am
Baird Upgrades Argenx (ARGX) Amid New Valuation Opportunities | ARGX Stock News
GuruFocus News • 4:45am
May 12, 2025
Argenx (ARGX) Faces Target Price Reduction by Deutsche Bank | ARGX Stock News
GuruFocus News • 2:45pm
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news